Year Founded
2018
Ownership
Private
Employees
~10
Therapeutic Areas
Oncology
Stage
Preclinical
Modalities
PeptidesmRNA vaccine

Frame Pharmaceuticals General Information

Company was acquired by CureVac for their neoantigen platform technology for mRNA cancer vaccines

Contact Information

Website
Primary Industry
[ "Biotech", "Pharma" ]
Corporate Office

Drug Pipeline

No pipeline data available

For full access to Frame Pharmaceuticals's pipeline data

Book a demo

Key Partnerships

CureVac

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Frame Pharmaceuticals Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Frame Pharmaceuticals's complete valuation and funding history, request access »

Frame Pharmaceuticals Investors

Privately funded startup—specific investors undisclosed
Investor Type: Venture Capital
Holding: Minority